Richard Newitter
Stock Analyst at Truist Securities
(3.75)
# 634
Out of 5,182 analysts
464
Total ratings
47.37%
Success rate
8.84%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Maintains: Hold | $89 → $90 | $83.46 | +7.84% | 24 | Apr 24, 2026 | |
| BSX Boston Scientific | Maintains: Buy | $90 → $85 | $59.95 | +41.78% | 24 | Apr 23, 2026 | |
| IRTC iRhythm Holdings | Maintains: Buy | $200 → $170 | $125.96 | +34.96% | 21 | Apr 15, 2026 | |
| VCEL Vericel | Maintains: Buy | $48 → $42 | $36.98 | +13.57% | 7 | Apr 15, 2026 | |
| SYK Stryker | Maintains: Hold | $395 → $380 | $329.01 | +15.50% | 26 | Apr 15, 2026 | |
| MDT Medtronic | Maintains: Hold | $103 → $95 | $82.92 | +14.57% | 20 | Apr 15, 2026 | |
| LNTH Lantheus Holdings | Maintains: Buy | $89 → $98 | $84.11 | +16.51% | 24 | Apr 15, 2026 | |
| ISRG Intuitive Surgical | Maintains: Buy | $650 → $580 | $470.99 | +23.14% | 33 | Apr 15, 2026 | |
| PODD Insulet | Maintains: Buy | $360 → $315 | $188.31 | +67.28% | 6 | Apr 15, 2026 | |
| INSP Inspire Medical Systems | Maintains: Hold | $70 → $64 | $55.07 | +16.22% | 32 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $9.86 | +82.56% | 3 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $18 | $10.65 | +69.01% | 7 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $27 → $35 | $19.82 | +76.59% | 6 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $30 | $24.09 | +24.53% | 17 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $19 → $20 | $15.82 | +26.42% | 11 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 → $24 | $13.15 | +82.51% | 2 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $97 | $85.35 | +13.65% | 13 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $82 → $80 | $61.41 | +30.27% | 4 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $370 → $374 | $327.98 | +14.03% | 8 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $4 → $3 | $1.92 | +56.25% | 19 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $145 | $122.07 | +18.78% | 7 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $93 → $105 | $93.70 | +12.06% | 30 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $13 → $15 | $10.69 | +40.32% | 19 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $140 → $137 | $135.07 | +1.43% | 38 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $118 → $113 | $92.59 | +22.04% | 32 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $7.29 | +174.35% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $71 → $82 | $76.01 | +7.88% | 5 | Aug 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $260 → $250 | $150.22 | +66.42% | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $26 | $2.39 | +987.87% | 4 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $690 → $770 | $184.70 | +316.89% | 10 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $5.18 | +286.10% | 1 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $27 | $39.39 | -31.45% | 5 | Feb 23, 2021 |
Edwards Lifesciences
Apr 24, 2026
Maintains: Hold
Price Target: $89 → $90
Current: $83.46
Upside: +7.84%
Boston Scientific
Apr 23, 2026
Maintains: Buy
Price Target: $90 → $85
Current: $59.95
Upside: +41.78%
iRhythm Holdings
Apr 15, 2026
Maintains: Buy
Price Target: $200 → $170
Current: $125.96
Upside: +34.96%
Vericel
Apr 15, 2026
Maintains: Buy
Price Target: $48 → $42
Current: $36.98
Upside: +13.57%
Stryker
Apr 15, 2026
Maintains: Hold
Price Target: $395 → $380
Current: $329.01
Upside: +15.50%
Medtronic
Apr 15, 2026
Maintains: Hold
Price Target: $103 → $95
Current: $82.92
Upside: +14.57%
Lantheus Holdings
Apr 15, 2026
Maintains: Buy
Price Target: $89 → $98
Current: $84.11
Upside: +16.51%
Intuitive Surgical
Apr 15, 2026
Maintains: Buy
Price Target: $650 → $580
Current: $470.99
Upside: +23.14%
Insulet
Apr 15, 2026
Maintains: Buy
Price Target: $360 → $315
Current: $188.31
Upside: +67.28%
Inspire Medical Systems
Apr 15, 2026
Maintains: Hold
Price Target: $70 → $64
Current: $55.07
Upside: +16.22%
Apr 15, 2026
Maintains: Buy
Price Target: $20 → $18
Current: $9.86
Upside: +82.56%
Apr 15, 2026
Maintains: Buy
Price Target: $25 → $18
Current: $10.65
Upside: +69.01%
Mar 19, 2026
Upgrades: Buy
Price Target: $27 → $35
Current: $19.82
Upside: +76.59%
Mar 2, 2026
Maintains: Buy
Price Target: $47 → $30
Current: $24.09
Upside: +24.53%
Mar 2, 2026
Maintains: Hold
Price Target: $19 → $20
Current: $15.82
Upside: +26.42%
Feb 24, 2026
Reiterates: Buy
Price Target: $23 → $24
Current: $13.15
Upside: +82.51%
Feb 20, 2026
Maintains: Buy
Price Target: $95 → $97
Current: $85.35
Upside: +13.65%
Feb 17, 2026
Reiterates: Buy
Price Target: $82 → $80
Current: $61.41
Upside: +30.27%
Jan 16, 2026
Downgrades: Hold
Price Target: $370 → $374
Current: $327.98
Upside: +14.03%
Dec 18, 2025
Maintains: Hold
Price Target: $4 → $3
Current: $1.92
Upside: +56.25%
Dec 18, 2025
Maintains: Buy
Price Target: $120 → $145
Current: $122.07
Upside: +18.78%
Nov 18, 2025
Reiterates: Buy
Price Target: $93 → $105
Current: $93.70
Upside: +12.06%
Oct 15, 2025
Maintains: Hold
Price Target: $13 → $15
Current: $10.69
Upside: +40.32%
May 5, 2025
Maintains: Hold
Price Target: $140 → $137
Current: $135.07
Upside: +1.43%
Feb 10, 2025
Reiterates: Hold
Price Target: $118 → $113
Current: $92.59
Upside: +22.04%
Aug 24, 2021
Initiates: Outperform
Price Target: $20
Current: $7.29
Upside: +174.35%
Aug 19, 2021
Maintains: Market Perform
Price Target: $71 → $82
Current: $76.01
Upside: +7.88%
Aug 6, 2021
Maintains: Market Perform
Price Target: $260 → $250
Current: $150.22
Upside: +66.42%
May 11, 2021
Maintains: Outperform
Price Target: $27 → $26
Current: $2.39
Upside: +987.87%
Apr 29, 2021
Maintains: Outperform
Price Target: $690 → $770
Current: $184.70
Upside: +316.89%
Feb 24, 2021
Initiates: Outperform
Price Target: $20
Current: $5.18
Upside: +286.10%
Feb 23, 2021
Maintains: Outperform
Price Target: $23 → $27
Current: $39.39
Upside: -31.45%